INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. – Trademark Portfolio

Entity Type: 03

INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 13 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. The owner is based in TARZANA, CA.

SUITE 211

18345 VENTURA BOULEVARD

TARZANA, CA 91356

24 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

INTERNATIONAL CARDIOVASCULAR MEDICINE, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (13 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (5 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. have?

INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. has 24 U.S. trademarks filed with the USPTO.

What trademark classes does INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. file in?

INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What is INTERNATIONAL CARDIOVASCULAR MEDICINE, INC.'s trademark registration success rate?

INTERNATIONAL CARDIOVASCULAR MEDICINE, INC. has a 0% trademark registration rate, with 0 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.